首页> 外文期刊>Journal of Breast Cancer >Patterns of Practice in Radiotherapy for Breast Cancer in Korea
【24h】

Patterns of Practice in Radiotherapy for Breast Cancer in Korea

机译:韩国乳腺癌放疗的实践模式

获取原文
       

摘要

pAdjuvant radiotherapy (RT) is a well-established treatment for breast cancer. However, there is a large degree of variation and controversy in practice patterns. A nationwide survey on the patterns of practice in breast RT was designed by the Division for Breast Cancer of the Korean Radiation Oncology Group. All board-certified members of the Korean Society for Radiation Oncology were sent a questionnaire comprising 39 questions on six domains: hypofractionated whole breast RT, accelerated partial breast RT, postmastectomy RT (PMRT), regional nodal RT, RT for ductal carcinoma in situ , and RT toxicity. Sixty-four radiation oncologists from 54 of 86 (62.8%) hospitals responded. Twenty-three respondents (35.9%) used hypofractionated whole breast RT, and the most common schedule was 43.2 Gy in 16 fractions. Only three (4.7%) used accelerated partial breast RT. Five (7.8%) used hypofractionated PMRT, and 40 (62.5%) had never used boost RT after chest wall irradiation. Indications for regional nodal RT varied; ≥pN2 (n=7) versus ≥pN1 (n=17) versus ≥pN1 with pathologic risk factors (n=40). Selection criteria for internal mammary lymph node (IMN) irradiation also varied; only four (6.3%) always treated IMN when regional nodal RT was administered and 30 (46.9%) treated IMN only if IMN involvement was identified through imaging. Thirty-one (48.4%) considered omission of whole breast RT after breast-conserving surgery for ductal carcinoma in situ based on clinical and pathologic risk factors. Fifty-two (81.3%) used heart-sparing techniques. Overall, there were wide variations in the patterns of practice in breast RT in Korea. Standard guidelines are needed, especially for regional nodal RT and omission of RT for ductal carcinoma in situ .
机译:>辅助放疗(RT)是一种公认​​的乳腺癌治疗方法。但是,实践模式存在很大的差异和争议。韩国放射肿瘤学小组乳腺癌科设计了一项全国性的乳腺癌放疗实践调查。已向韩国放射肿瘤学会的所有经过董事会认证的成员发送了一个问卷,该问卷包含以下六个领域的39个问题:全分割的全乳RT,加速的部分乳腺RT,乳房切除术后RT(PMRT),局部淋巴结RT,导管癌原位RT,和RT毒性。来自86家医院中的54家(64.8%)的64位放射肿瘤学家对此做出了回应。 23名受访者(35.9%)使用了全分割的全乳RT,最常见的时间表是16馏分中的43.2 Gy。只有三分之四(4.7%)的人使用了局部乳腺RT。 5例(7.8%)使用了次等级PMRT,而40例(62.5%)从未在胸壁照射后使用boost RT。区域性淋巴结转移的适应证各不相同; ≥pN2(n = 7)与≥pN1(n = 17)与≥pN1,且具有病理危险因素(n = 40)。内部乳腺淋巴结(IMN)照射的选择标准也有所不同。只有在通过影像学发现IMN受累时,才进行区域淋巴结RT治疗的患者中只有4名(6.3%)接受IMN治疗,另有30名(46.9%)接受IMN治疗。根据临床和病理危险因素,有31位(48.4%)认为保留乳腺导管癌的原位保乳手术后全乳RT漏诊。 52(81.3%)个使用了保留心脏的技术。总体而言,韩国乳房RT的实践方式差异很大。需要标准指南,尤其是对于区域性淋巴结放疗和导管癌原位放疗的遗漏。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号